CClinicalTrials.gg
Not yet recruitingNCT06262802Updated Feb 16, 2024

Volumetric Changes in Large Cystic Lesions Using Active Decompression and Distraction Sugosteogenesis vs Passive Decompression

An interventional study of Active decompression in Odontogenic Cysts, sponsored by Radwa Hydar Ragab. Not yet recruiting. Open to participants aged 12 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-02-16.

Sponsored by Radwa Hydar Ragab · Not applicable, Interventional, and Device feasibility

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
12 Years to 80 Years
Sex
All
01

Study summary

Null hypothesis active decompression and distraction sugosteogenesis is not faster than passive decompression in volume reduction of large cystic lesions

02

Conditions studied

  • Odontogenic Cysts
03

In context

Lead sponsor

This is the only study on the registry with Radwa Hydar Ragab as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • any patient with large cystic lesion

Exclusion criteria

Exclusion Criteria:

  • any patient can't follow home instructions
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Intervention

    Device: Active decompression

  • Active comparator
    Control

    Device: Active decompression

Interventions

  • DeviceActive decompression

    Intracystic active negative pressure

06

What researchers measure

Primary outcomes

  1. Volume change

    Percentage of volume changes over time

    Time frame: 2weeks/one and 6 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06262802
Lead sponsor
Radwa Hydar Ragab
Responsible party
Radwa Hydar Ragab (Principle investigator, Cairo University) — Sponsor-investigator
First posted
Feb 16, 2024
Start date
Mar 1, 2024 (estimated)
Primary completion
Sep 1, 2024 (estimated)
Completion
Mar 1, 2025 (estimated)
Last update
Feb 16, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion